Advertisement
The generation and validation of hypotheses that drive drug discoveryinvolves constant scanning of massive volumes of scientific literature,patents, adverse event reports, company reports, news, patient generatedcontent, etc. While the intellectual capacity of experts in digesting andunderstanding this information is still vital today, the creative thinkingprocess can benefit a lot from automatic support of appropriate softwaresolutions. Such a solution needs to be capable of detecting the specificconcepts of the Life Sciences domain such as biological and chemical entitiesor diseases as well as their respective relations to one another. It alsorequires easy customization capabilities, industrial strength and highperformance. The result of such an analysis must be made accessible throughan intuitive interface in order to allow for the efficient detection ofrelevant pieces of information, and also for in-depth data mining.
Advertisement
"The fact that the team of Merck KGaA with the rare and pronounced doublecompetence in both pharma research and natural language processing decides togo with TEMIS in order to satisfy their text mining needs is a valuableacknowledgement of the quality of our software solution", says StefanGeissler, Managing Director of TEMIS Deutschland GmbH. "Merck KGaA is adetermined and creative client and it is evident that the cooperation will beequally fruitful for both partners."
About TEMIS
Founded in 2000, TEMIS is the leading provider of Corporate Text Miningand Text Analytics software solutions for the Enterprise. TEMIS addresses theunstructured data management needs of Corporations (Life Sciences, Publishingor Manufacturers) and Governments, in environments where informationprocessing is critical such as Competitive Intelligence, CRM, ScientificIntelligence, IP Management, Quality Management and Homeland Security.
TEMIS solutions help thousands of users everyday gain immediate access tobusiness critical information, using entities and relations extraction,automatic classification and semantic navigation, in order to reduceinformation overload.
TEMIS' innovative technology has attracted major organizations such asEMC, Novartis, Sanofi-Aventis, Boehringer Ingelheim, BASF, Bayer Healthcare,Solvay Pharmaceuticals, Ingenuity, Thomson Reuters, Agence France-Presse,Springer Science+Business Media, Elsevier, Bertelsmann, Total, GDF SUEZ, PSAPeugeot-Citroen, BNP Paribas, French Ministry of Defense, Europol, Invest inFrance Agency.
http://www.temis.com
SOURCE TEMIS
